These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

31 related articles for article (PubMed ID: 13948146)

  • 1. Reply to: "Ammonia predicts clinical outcomes in cirrhosis - but there are caveats to consider".
    Ballester MP; Carbonell-Asins JA; Balcar L; Reiberger T; Jalan R
    J Hepatol; 2023 Dec; 79(6):e239-e241. PubMed ID: 37625482
    [No Abstract]   [Full Text] [Related]  

  • 2. A method for the determination of glutamine in cerebrospinal fluid and the results in hepatic coma.
    WHITEHEAD TP; WHITTAKER SR
    J Clin Pathol; 1955 Feb; 8(1):81-4. PubMed ID: 14354038
    [No Abstract]   [Full Text] [Related]  

  • 3. CEREBROSPINAL FLUID GLUTAMINE LEVEL IN PORTAL CIRRHOSIS OF THE LIVER.
    LAHA PN; KOCHAR BK
    J Assoc Physicians India; 1964 Jun; 12():431-6. PubMed ID: 14182701
    [No Abstract]   [Full Text] [Related]  

  • 4. [CLINICAL SIGNIFICANCE OF THE DETERMINATION OF GLUTAMINE IN THE CEREBROSPINAL FLUID. (RESULTS IN 50 CASES)].
    SCHAPOSNIK F; RAULDUMM F
    Rev Clin Esp; 1964 Jun; 93():377-84. PubMed ID: 14183647
    [No Abstract]   [Full Text] [Related]  

  • 5. [Blood ammonium, glutamine in the cerebrospinal fluid, the electroencephalogram and the neurological examination in relation to states of consciousness in hepatic patients].
    VELASCO M; VACCAREZZA A; GALVEZ S; CHIOFFALO N; KLINGER J; KATZ R; CUEVAS M; CUEVAS N
    Rev Med Chil; 1961 Oct; 89():767-71. PubMed ID: 13925220
    [No Abstract]   [Full Text] [Related]  

  • 6. Glutamine estimation in cerebrospinal fluid in cases of liver cirrhosis and hepatic coma.
    GILON E; SZEINBERG A; TAUMAN G; BODONYI E
    J Lab Clin Med; 1959 May; 53(5):714-9. PubMed ID: 13654912
    [No Abstract]   [Full Text] [Related]  

  • 7. [Glutaminorachia during liver cirrhosis. Semeiological value of its modifications in "hepatic encephalopathies"].
    GIRARD M; DORCHE J; REVILLARD JP; BEL A; VALLON C; NYSSEN ; MINAIRE Y
    J Med Lyon; 1962 Sep; 43():1303-38. PubMed ID: 13948146
    [No Abstract]   [Full Text] [Related]  

  • 8. Management of hepatic encephalopathy in patients with cirrhosis.
    Wright G; Jalan R
    Best Pract Res Clin Gastroenterol; 2007; 21(1):95-110. PubMed ID: 17223499
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of oral branched-chain amino acids on hepatic encephalopathy and outcome in patients with liver cirrhosis.
    Kawaguchi T; Taniguchi E; Sata M
    Nutr Clin Pract; 2013 Oct; 28(5):580-8. PubMed ID: 23945292
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ammonia and amino acid profiles in liver cirrhosis: effects of variables leading to hepatic encephalopathy.
    Holecek M
    Nutrition; 2015 Jan; 31(1):14-20. PubMed ID: 25220875
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Branched-chain amino acids and ammonia metabolism in liver disease: therapeutic implications.
    Holecek M
    Nutrition; 2013 Oct; 29(10):1186-91. PubMed ID: 23756281
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathogenesis of hepatic encephalopathy in cirrhosis: the concept of synergism revisited.
    Butterworth RF
    Metab Brain Dis; 2016 Dec; 31(6):1211-1215. PubMed ID: 26521983
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.